Basic Information
Xhale, Inc. was established at the end of 2005 based on intellectual property and patents licensed from the University of Florida. In 2006, the company began product development using its SMART® medication adherence monitoring technology and propofol monitor. It is dedicated to developing products aimed at transforming healthcare and saving lives.